View in EDS HTML Full Text PDF Full Text

First-Line Treatment with Tivozanib for Metastatic Renal Cell Carcinoma in Real-World Settings Across Germany: Results of the Prospective, Non-Interventional, Post-Approval Study T-Rex.

Saved in:
Bibliographic Details
Title: First-Line Treatment with Tivozanib for Metastatic Renal Cell Carcinoma in Real-World Settings Across Germany: Results of the Prospective, Non-Interventional, Post-Approval Study T-Rex.
Authors: Grünwald, Viktor1 (AUTHOR) viktor.gruenwald@uk-essen.de, Rußwurm, Karen2 (AUTHOR), Eckert, Ralf3 (AUTHOR), Seseke, Sandra4 (AUTHOR), Standhaft, Diana5 (AUTHOR), Hegemann, Miriam6 (AUTHOR), Baumann, Steffen7 (AUTHOR), Brenneis, Horst8 (AUTHOR), Seidel, Michael9 (AUTHOR), Rau, Olrik10 (AUTHOR), Schirrmacher-Memmel, Silke11 (AUTHOR), Hellmis, Eva12 (AUTHOR), Fieseler, Claus F.13 (AUTHOR), Doehn, Christian14 (AUTHOR), Ziske, Carsten15 (AUTHOR), Distelrath, Andrea16 (AUTHOR), Marschner, Norbert17 (AUTHOR), Ivanyi, Philipp18 (AUTHOR), Herold, Martin19 (AUTHOR), Loehr, Bianca I.19,20 (AUTHOR)
Source: Cancers. Dec2025, Vol. 17 Issue 24, p3910. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers17243910